Clinical Trials Logo

Spinal Induced Hypotension clinical trials

View clinical trials related to Spinal Induced Hypotension.

Filter by:
  • None
  • Page 1

NCT ID: NCT05862298 Recruiting - Clinical trials for Intravascular Volume

Spinal-Induced Hypotension in Geriatric Patients

Start date: May 1, 2023
Phase:
Study type: Observational

The study will be conducted to asses preoperative condition of venous system by VExUS score and it's relation with the incidence of spinal induced hypotension in geriatric patients undergoing surgery with spinal anaesthesia.

NCT ID: NCT05127876 Completed - Clinical trials for Spinal Induced Hypotension

Ephedrine Versus Ondansetron During Cesarean Delivery

Start date: January 10, 2022
Phase: Phase 4
Study type: Interventional

More than 30% of the patients receiving spinal anesthesia develop hypotension. Hypotension developed during cesarean section (C/S) under spinal anesthesia may jeopardize uteroplacental circulation leading to fetal compromise and even fetal death. The effect of prophylactic ondansetron on blood pressure after spinal anesthesia has not been compared in a clinical trial with that of a vasoconstrictor. The investigators will compare ephedrine and ondansetron for the prevention of maternal hypotension after spinal anesthesia for elective cesarean delivery.

NCT ID: NCT04789005 Completed - Clinical trials for Spinal Induced-hypotension

Comparison of Phenylephrine and Norepinephrine for Spinal-induced Hypotension

Start date: November 10, 2019
Phase: Phase 3
Study type: Interventional

Hypotension after spinal anaesthesia for cesarean deliveries is frequently encountered. Phenylephrine an α-agonist is commonly used for the prevention and treatment of spinal-induced hypotension. Phenylephrine causes baroreceptor-mediated bradycardia leading to subsequent reduction in cardiac output. Preservation of heart rate and cardiac output is important in high-risk conditions such as placental insufficiency, fetal distress and maternal cardiac disease. Recently, norepinephrine has been found as effective as phenylephrine in treatment of spinal induced hypotension. When norepinephrine is used as a bolus, it is effective at maintaining blood pressure while also conferring a greater heart rate and cardiac output compared to phenylephrine.

NCT ID: NCT04195321 Completed - Elderly Clinical Trials

Norepinephrine Versus Phenylephrine for Preventing Spinal Anesthesia Induced Hypotension in Elderly

Start date: January 1, 2020
Phase: Phase 4
Study type: Interventional

Various regimens were used for prevention of hypotension; most of these regimens included the use of vasopressors. Ephedrine is commonly used vasopressor for management and prophylaxis of hypotension; however, ephedrine is usually associated with tachycardia which increases oxygen consumption; thus, it might be potentially harmful in this special group of patients. Phenylephrine (PE) is another vasopressor which is characterized by α agonistic activity. PE had been the preferred vasopressor for prophylaxis against post-spinal hypotension especially in obstetric population. it was reported that PE improved the intraoperative hemodynamic profile in elderly patients undergoing lower extremities orthopedic surgery under spinal anesthesia. PE (a pure α agonist) was reported to decrease cardiac output which limit its use in patients with compromised cardiac contractility; this fact makes the use of PE in elderly patients questionable. Norepinephrine (NE) is characterized by α agonistic and weak β agonistic activity; thus, NE is characterized by less cardiac depression compared to PE. NE was recently introduced for prophylaxis against post-spinal hypotension in obstetric anesthesia. In non-obstetric population, although, NE infusion effectively maintained patients hemodynamics during general anesthesia, its use during spinal anesthesia was not adequately evaluated in elderly population

NCT ID: NCT03091881 Completed - Clinical trials for Spinal-induced Hypotension

Granisetron in Diabetic Parturients Decrease Spinal Induced Hypotension

Start date: March 1, 2018
Phase: Phase 4
Study type: Interventional

Diabetic Parturients are exposed to intraoperative hypotension after spinal anesthesia and we proposed that intravenous Granisterone 1 mg will attenuate the hypotension occurred with spinal block during Cesarean sections.

NCT ID: NCT01967914 Completed - Clinical trials for Spinal Induced Hypotension

PVI for Prediction of Spinal Induced Hypotension

Start date: October 2013
Phase: N/A
Study type: Observational

The hypothesis is that plethysmography variability index can predict the occurrence of hypotension after spinal anesthesia for cesarean delivery